GHRL and metabolic dysfunction-associated steatotic liver disease: 919 syrup reversed the abnormal gene expression of the Ghrelin pathway in the brain and stomach under NAFLD conditions, regulated feed intake and body weight, and improved intestinal microbiota disturbance in rats with NAFLD.